| Bioactivity | Cyclo(Arg-Gly-Asp-(D-Phe)-Glu) (c(RGDfE)) is a cyclic RGD peptide that serves as a conjugated multifunctional nanodrug delivery system to target Gemcitabine to pancreatic cancer cells. Cyclo(Arg-Gly-Asp-(D-Phe)-Glu) can be used in cancer research[1]. |
| Name | Cyclo(Arg-Gly-Asp-(D-Phe)-Glu) |
| CAS | 756500-22-8 |
| Sequence | Cyclo(Arg-Gly-Asp-{d-Phe}-Glu) |
| Shortening | Cyclo(RGD-{d-Phe}-E) |
| Formula | C26H36N8O9 |
| Molar Mass | 604.61 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sun J , et al. A c(RGDfE) conjugated multi-functional nanomedicine delivery system for targeted pancreatic cancer therapy. J Mater Chem B. 2015 Feb 14;3(6):1049-1058. |
Cyclo(Arg-Gly-Asp-(D-Phe)-Glu)
CAS: 756500-22-8 F: C26H36N8O9 W: 604.61
Cyclo(Arg-Gly-Asp-(D-Phe)-Glu) (c(RGDfE)) is a cyclic RGD peptide that serves as a conjugated multifunctional nanodrug d
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.